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Vascular development involves de novo formation of a capillary plexus, which is then pruned and 24 remodeled by angiogenic events. Cytoskeletal remodeling and directional endothelial migration are 25 essential for developmental and pathological angiogenesis. Smad-dependent TGF signaling controls 26 vascular patterning and is negatively regulated by microtubules. Here we show that a positive regulator 27 of TGF signaling is essential for developmental vascular patterning and microtubule stability. 28 Rudhira/BCAS3 is known to bind microtubules and to play a nodal role in cytoskeletal remodeling and 29 directional endothelial cell (EC) migration in vitro. We demonstrate that the molecular and cellular 30 function of Rudhira is deployed at critical steps in vascular patterning. We generated the first floxed 31 mice for rudhira and find that global or endothelial knockout of rudhira results in mid-gestation lethality 32
due to aberrant embryonic and extra-embryonic vessel patterning and defective cardiac morphogenesis. 33
Rudhira null yolk sac ECs show random and retarded migration. Yolk sac transcriptome analysis revealed 34 key mediators of angiogenic processes and TGF receptor signaling were perturbed in rudhira null 35 mutants. Molecular and biochemical analyses showed that rudhira depletion reduced microtubule 36 stability but increased expression of pathway inhibitors leading to high levels of SMAD2/3 ubiquitination 37 and reduced activation. These effects were not rescued by exogenous TGFβ. However, TGF treatment 38 of wild type ECs increased Rudhira expression. Further, exogenous Rudhira, which promotes directional 39 cell migration, caused increased SMAD2/3 nuclear translocation and reduced inhibitor levels. Therefore, 40
we propose that Rudhira and TGF signaling are mutually dependent. Rudhira has a dual function in 41 promoting TGF signaling, possibly by sequestering microtubules and simultaneously preventing 42 SMAD2/3 ubiquitination to permit EC migration and vascular patterning. TGF signaling and aberrant 43 human Rudhira (Breast Cancer Amplified Sequence 3, BCAS3) expression are both associated with 44 tumour metastasis. Our study identifies a cytoskeletal, cell type-specific modulator of TGF signaling 45 important in development and cancer. 46
Author Summary Introduction
61
Vertebrate blood vessel formation involves de novo differentiation of endothelial cells (ECs) to form a 62 primary plexus (1). This is resolved into a branched hierarchical network by EC migration and inhibition 63 of proliferation, basement membrane reconstitution and recruitment of smooth muscle cells and 64 pericytes to stabilize the network (2-4). Perturbation of the balance between pro-and anti-angiogenic 65 cues leads to endothelial activation and cytoskeletal changes resulting in sprouting, migration and 66 maturation (5, 6 ). This process is spatially and temporally orchestrated during development and adult 67 neo-angiogenesis. Recent studies have elegantly elucidated the cellular dynamics of vessel regression 68 and pruning (7, 8) . EC migration and tube formation are key steps during angiogenesis, however, 69 molecular mechanisms that operate are incompletely defined. Random and retarded EC migration 70 results in an unpatterned, often leaky vasculature (9, 10) . 71
A primary response of EC to angiogenic stimuli, flow induced shear stress or signals that induce pruning, 72 is the reorganization of the cytoskeleton, resulting in activation of various signaling pathways (11) (12) (13) . 73
The loss of EC polarity, actin reorganization and extracellular matrix remodeling are key outcomes of 74 cytoskeletal remodeling, resulting in directional cell migration essential for angiogenesis. The 75 cytoskeleton also induces changes in cell shape and gene expression through a complex network of 76 signaling pathways by influencing transcription factor activity (14) . 77
The TGFβ pathway is sensitive to cytoskeletal rearrangements and regulates EC proliferation, 78 differentiation, survival and migration (15) We report that global or EC-specific rudhira deletion results in mid-gestation lethality due to aberrant 96 vascular patterning. Knockout ECs fail to show directed migration. In rudhira mutants, hierarchical 97 patterning of the embryonic and extra-embryonic vasculature is lost. Expectedly, this has a major effect 98 on gene expression as seen by yolk sac transcriptome and protein expression studies. While several 99 processes and signaling pathways involved in vascular patterning are perturbed, extracellular matrix 100 remodeling and TGF signaling are majorly affected. We show that Rudhira does not induce, but 101 promotes TGFβ signaling by suppressing expression of the inhibitor smurf2, thereby preventing 102 SMAD2/3 ubiquitination. Further, Rudhira shows increased association with microtubules upon TGF 103 induction. Thus Rudhira provides cytoskeletal control of several angiogenic processes by modulating 104 TGF signaling. This indicates that normal Rudhira function is required to aid the EC cytoskeleton in 105 regulating gene expression and cell migration. The identification and mechanistic deciphering of genes 106 such as rudhira, provide us a pivot on which molecular partnerships with both ubiquitous 'essential' or 107 'redundant' players can be understood and deciphered in the EC context. 108
Results
109
Endothelial rudhira is vital for embryonic development 110 Rudhira is expressed primarily in early embryonic vascular development and neo-angiogenesis, but its 111 role in vivo is not known. Hence we generated rudhira floxed mice ( Fig. 1A and S1A Fig.) and Methods, and S1 Fig.) . While heterozygotes were viable, ubiquitous or endothelial deletion of 115 rudhira gave no live homozygous pups (S1A and S1B Tables). This indicates that endothelial deletion of 116 rudhira causes recessive embryonic lethality. Analysis of embryos from E8.5 to E11.5 showed a reduced 117 number of homozygous mutant embryos (S1A and S1B Tables) as identified by genotyping (Fig. 1B) , 118 transcript ( Fig. 1C ) and protein (S1B and S1C Fig.) expression, suggesting that lethality occurred between 119 E9.0 and E11.5. 120
Since rudhira expression may be transient or undetectable in some migrating cells we also analysed the 121 effect of globally deleted rudhira (rudh -/-) on development from E7.5 onwards, a stage before rudhira 122 expression is initiated (22). At E7.5 rudhira mutant embryos were indistinguishable from controls with 123 respect to morphology as well as primitive streak formation as seen by Brachyury expression (S1D Fig.) . 124 E8.5 mutant embryos showed unpatterned dorsal aorta as detected by Flk1 staining (S1E Fig.) . By E9.5, 125 mutant embryos were growth retarded ( Fig. 1D and 2A ) with defects including reduced somite number 126 (19±2 at E9.5 in mutants compared to 25±2 in controls; n= 10) but expressed lineage markers of 127 ectoderm (Nestin), mesoderm (Brachyury) and endoderm (AFP) (S1F Fig.) . Rudhira is known to have 128 restricted expression during vasculogenesis and primitive erythropoiesis (22). However, we did not find 129 any significant change in the expression of vascular (CD34, Flk1, Ephrin, SMA, PECAM) and early 130 hematopoietic (β-globin, c-kit, GATA-1) markers by semi-quantitative RT-PCR (S1F Fig.) showing that the 131 two lineages are specified in rudhira null embryos. This suggests that rudhira is not essential for lineage 132 specification and early vascular differentiation. Hence, we reasoned that the growth retardation and 133 morphological defects seen in rudhira null embryos likely arise from defects in vascular rearrangement 134 and patterning. 135
136
Rudhira functions in extraembryonic vascular development 137
Impaired development and embryonic lethality between E8.5-E11.5 is often the result of aberrant and 138 functionally impaired extra-embryonic vasculature (24). Moreover, Rudhira is strongly expressed in the 139 yolk sac vasculature (22). Hence we analysed extraembryonic structures of mutant embryos, such as 140 yolk sac and placenta which connect the maternal and fetal vasculature. Mutant yolk sacs were pale and 141 lacked major blood vessels (Fig. 1D) . Immunostaining for the blood vessel marker PECAM showed that 142 rudh -/-yolk sac vessels were irregular and fused, unlike the finely patterned honey-comb like vascular 143 network seen in control littermates (Fig. 1E, 1I -K). Thus mutants could form a primitive vascular plexus 144 which, however, did not undergo angiogenic remodeling. Primitive erythrocytes were dispersed all over 145 the mutant yolk sac indicating an unpatterned and leaky vasculature. Histological analyses of yolk sac 146 showed congested capillaries lined by thinner endothelium (Fig. 1F, arrowhead) as compared to controls 147 (Fig. 1F, arrow) . To test whether the yolk sac vessel patterning requires endothelial rudhira or is due to 148 non-specific effects we analysed endothelial-deleted rudh CKO yolk sac. Although of less severity than in 149 the global knock-out, endothelial deletion of rudhira resulted in reduced branching from major vessels, 150 vessel fusion and loss of branch hierarchy at both E10.5 and E11.5 (Fig. 1G-H and I-K). These results 151 indicate that rudhira is essential for remodeling the yolk sac vascular network. Aberrant vascular 152 remodeling in rudhira mutant embryos is likely the primary cause of death. 153 Control placenta showed a distinct chorionic plate, labyrinth, spongiotrophoblast and decidual layers. 172
Rudh
-/-placenta lacked stratified layers with a greatly reduced labyrinth and chorionic plate composed 173 mostly of trophoblast giant cells. Fetal blood vessels could not invade into the placenta of rudh -/-and 174 contained fewer Ly76+ fetal erythrocytes as compared to controls where maternal (arrows) and fetal 175 (arrowheads) blood cell pockets co-existed (S2C and S2D Fig.) . Upon endothelial deletion of rudhira with 176
Tie2-Cre (rudh CKO ), placental thickness was reduced in mutant embryos at both E10.5 and E11.5 (S2E, 177 S2F, S2I, S2J and S2M Fig.) . Fetal vessel invasion was comparable to control at E10.5 (S2G and S2H Fig.)  178 and was found to be affected only at E11.5 (S2K and S2L Fig.) although not as severely as in the global 179 knock-out. This could explain the absence of significant growth retardation in conditional mutant 180
embryos. 181
Taken together, these findings suggest that rudhira is essential for fetal vessel invasion into the 182 developing placenta. Further, growth retardation in rudh -/-embryos is likely a result of defective 183 placental circulation. 184
185
Rudhira plays a key role in cardiovascular development and tissue patterning 186
Since rudh -/-embryos survived to E9.5 and rudh CKO survived to E11.5, we analyzed both genotypes for 187 embryonic development and vascular patterning ( To test whether rudhira null ECs also show slow and random migration, we cultured yolk sac ECs and 213 tested them in a wounding assay (Fig. 3A) . Rudhira null ECs also showed reduced migration rate and 214 decrease in directed migration ( Fig. 3B and 3C ). Taken together, our results demonstrate a key role for 215 Rudhira in directed cell migration, essential for vascular remodeling during developmental angiogenesis. 216 
Rudhira regulates expression of the angiogenesis network 238
Rudhira regulates actin dynamics which is known to affect nuclear transcription. We performed whole 239 transcriptome-based analysis of gene expression in rudhira knockout yolk sac and embryos at E9.5 to 240 determine its effect on vascular remodeling. While Rudhira expression is primarily in the endothelium, 241 our studies in vitro ((23) and this report) indicated that changes in Rudhira expression and localization 242 are rapid and depend on inter-cellular and cell-ECM interactions. Hence we chose to analyze intact 243 tissue with minimal manipulation to understand how Rudhira affects the transcriptome. While embryos 244 at E9.5 have a diverse set of derivatives of all three germ layers, yolk sacs are primarily made of 245 primitive endoderm and mesoderm, the latter comprising mainly endothelial and hematopoietic 246 lineages. Hence we separately analyzed rudh -/-embryos and yolk sacs to avoid confounding effects of 247 possible mosaic deletion of rudhira in the Tie2-Cre conditional knockout. We then extensively validated 248 the data by quantitative PCR-based expression analysis of yolk sac RNA and endothelial cell line RNA. 249
Volcano plot based method was used to visualize the transcripts that are two-fold differentially 250 expressed in yolk sac (Fig. 3D) . 3291 unique probes showed 2-fold or greater statistically significant 251 changes in gene expression (S2 Table) . Of these 546 were downregulated and 334 upregulated in 252 embryo and 566 downregulated and 1960 upregulated in yolk sac (Fig. 3E) . 29 downregulated genes and 253 43 upregulated ones were common between embryo and yolk sac ( Fig. 3E and S3 Table) . Unsupervised 254 hierarchical cluster analysis showed that genes with similar expression patterns were clustered together 255 with branch distance proportional to their similarity in expression pattern. A distinct sub set showed 256 reciprocal expression between embryo and yolk sac (Fig. 3F) . Interestingly the majority of clustered 257 genes were mainly upregulated in the yolk sac ( Fig. 3F and 3G ), while the embryo had a more balanced 258 distribution in each cluster (Fig. 3F) . To define how changes in gene expression caused by rudhira 259 depletion may influence vascular development and remodeling, we functionally annotated the data 260 using DAVID (Database for Annotation, Visualization and Integrated Discovery) and found that genes 261 linked to many biological pathways were enriched. Key deregulated biological categories were identified 262 (Fig. 3H) . 263
Analysis of the entire data set showed greater variation between duplicates of embryo than yolk sac, 264 possibly because of heterogeneity in the embryonic tissue. Hence for further analysis we focused on 265 yolk sac data as it is also the primary site of vascular remodeling and shows early Rudhira expression. 266
Significant expression changes were seen in genes that relate to a range of processes or pathways, 267 which could impact on vascular development and remodeling (Fig. 3H and S4 Fig. and S5 Table) . Gene 268 ontology analysis of the common genes identified principal biological processes affected by the loss of 269 rudhira with a Z score above 2.5. Amongst signaling pathways, negative regulation of the transforming 270 growth factor beta (TGF) signaling pathway was identified as significantly perturbed. Other pathways 271 implicated in vascular development such as Wnt, JAK/STAT and Notch signaling showed changed levels 272 of a few genes but expression of the majority of the pathway components was unaffected. Important 273 regulators of cellular processes such as angiogenesis/blood vessel remodeling, extracellular matrix, 274 regulation of proteolysis, negative regulation of peptidase activity and cell projection organization were 275 identified. Further, key molecular families involved in cytoskeletal remodeling, cell adhesion, cell 276 migration and TGF and VEGF pathways (all important during angiogenesis) were connected by Rudhira/ 277 BCAS3 allowing us to identify the Rudhira network in angiogenesis (Fig. 3I and S6 Table) . 278 279
Identification of regulatory networks and nodes regulated by Rudhira 280
A total of 140 genes from cluster analysis were enriched in the key gene ontology (GO) and pathways 281 identified (S5 Table) with a significance criterion of p<0.05. Further, we were able to associate GOs and 282 pathways known to co-operate during vascular development and remodeling namely adhesion, 283 angiogenesis, cytoskeleton, ECM organisation, peptidase activity and TGF signaling (Fig. 3I) . Genes 284 differentially expressed in these six processes were subjected to unsupervised hierarchical clustering to 285 identify molecular signatures (Fig. 4A, 5A and S4 Fig.) . An interaction network of significant GO terms 286 was assembled into a GO map to depict the relationship among prominent functional categories (Fig. 4B , 287 5B and S4 Fig.) . Subsequent verification of expression data was carried out for key genes known to 288 mediate these processes (Fig. 4C, 5C, 5D and S4 Fig.) . 51 out of the 3407 genes that showed significant 289 variation from control in the knockout yolk sac were validated by qPCR on cDNA generated from rudhira 290 knockdown and non-silencing control endothelial cell line RNA (Fig. 4C, 5C , 5D and S4 Fig.) and 70% of 291 these (36/51) agreed with array data. Changes in expression level of selected candidates were further 292 validated using cDNA generated from fresh E9.5 yolk sac RNA (S4F Fig.) . 293 Yolk sac transcriptome analysis revealed several processes important for angiogenesis that were 308 perturbed upon rudhira depletion. Extracellular matrix was an over-represented functional category, in 309 which genes for matrix components and ECM proteases are aberrantly expressed ( Fig. 4A and 4B) . 310
Controlled ECM remodeling is important for cell migration. Mutations that affect the dynamic regulation 311
and crosstalk between the cell and ECM are also known to affect tissue patterning and homeostasis (26). 312 MMP10, MMP21 and MMP25 were aberrantly expressed while TIMPs (Tissue inhibitors of 313 metalloproteases) were not significantly changed in rudh -/-yolk sacs. Expression of a large number of the 314 serine protease inhibitors was aberrant with eight members downregulated and eleven upregulated 315 ( Fig. 4B and S2 Table) . Interestingly several members of the extracellular Serpina clade were 316 downregulated (6/8) whereas the intracellular Serpinb clade was upregulated (8/9). Serpinb clade 317 members inhibit Granzyme (Gzm) activity (27). In the rudh -/-yolk sac Gzmd and Gzmg transcripts were 318 upregulated suggesting a loss of balance between production of proteases and protease inhibitors. A 319 disintegrin and metallopeptidase domain (Adam) class of endopeptidases namely Adam11, Adam24, 320
Adam32, Adam7, Adamts12, and Adamts15 were all significantly upregulated in rudh -/-yolk sacs. This 321 suggested that matrix organization or degradation may be affected. 322 ECM degradation is an essential step in angiogenesis and vascular patterning (28, 29) . Collagen type IV is 323 a major component of the vascular basement membrane. Of 11 collagen family members affected by 324 loss of rudhira, 7 were downregulated (Fig. 4B) . In situ zymography on live rudh CKO yolk sac and embryo 325 sections at E10.5 using dye quenched (DQ) gelatin showed absence of or significant decrease in signal 326 around vessels indicating reduced matrix degradation as compared to controls ( Fig. 4D and S5A Fig.) . 327
Sections were stained for collagen and laminin post zymography (S5A and S5D Fig.) . Both rudh CKO yolk 328 sacs and embryos showed highly disorganized collagen around the vessels (Fig. 4E and S5B Fig.) . Further, 329
Rudhira expression in vessels of control embryos overlapped with collagen staining (S5B and S5C Fig.) . 330
Co-staining of fixed sections of yolk sac and embryos with endothelial marker PECAM and ECM markers 331
showed that the organization of the matrix components collagen, fibronectin and laminin was disrupted 332 (Fig. 4E-G, S5 Fig.) . These results indicate that Rudhira is essential for maintaining proper ECM 333 organisation. TGFβ signaling plays a major role in regulating genes involved in ECM deposition and 334 degradation. As levels of several transcripts of the TGFβ pathway were altered in rudhira mutant yolk 335 sac ( Fig 5A, 5B and 5H) we analysed this pathway further. 336 337
Regulation of TGF signaling by Rudhira 338
TGFβ pathway was one of the major over-represented categories as levels of several of the TGFβ 339 pathway molecules were altered in rudhira mutant yolk sac (Fig 5A, 5B and 5I ). The TGFβ pathway is 340 essential for vascular patterning and angiogenesis. Deletion of TGFβ1 leads to delayed wound healing 341 (30). Ablation of TGFβRI or TGFβRII results in embryonic lethality with severe patterning defects (31, 32). 342 A significant decrease in expression of TGFb2, TGFb3 and TGFbr2 was seen in the microarray analysis 343 and subsequent validation by qRT-PCR (Fig 5A-D and Fig 5I) . TGFβ antagonists like Smurf1, Smurf2 and 344 Smad7 were upregulated in rudhira knockdown ECs (Fig 5D) . TGF is produced by the yolk sac ECs and is 345 also available as a paracrine signal from the yolk sac endoderm and embryonic tissue (18). This activates 346 the SMAD2 effector which leads to the differentiation of vascular smooth muscles cells and promotes 347 their association with endothelial cells, to establish a properly patterned vasculature. Reduced pSMAD2 348 levels in Smad2/3 and endoglin mutants co-relate with an unpatterned vasculature and mid-gestation 349 lethality (18, 33). To assess pSMAD2 levels in the absence of Rudhira, we stained control and rudh CKO 350 yolk sacs for pSMAD2. Mutant yolk sacs had fewer pSMAD2 positive endothelial cells (Fig. 5E, arrows) . 351
Upon induction of live yolk sacs with exogenous TFG control yolk sacs showed increased pSMAD2, 352 whereas rudh CKO yolk sacs continued to show low pSMAD2 signal in the endothelial cells (Fig. 5E,  353 arrowheads). Similarly, rudhira knockout embryo-derived endothelial cells or rudhira knockdown 354 endothelial cell line (SVEC KD) treated with TGF also failed to activate pSMAD2 as compared to controls 355 ( Fig. 5F and Fig. 5G respectively, and S6A Fig.) . This suggests that Rudhira is essential for TGF pathway 356 activation via pSMAD2. 357 
Rudhira functions downstream of TGF receptor activation 383
To test whether provision of TGF could rescue the cell migration defect seen upon rudhira depletion, 384
we cultured SVEC knockdown cells in the presence of exogenous TGF Provision of exogenous TGF in a 385 cell monolayer wounding assay did not rescue the migratory defects of rudhira-depleted endothelial 386 cells migrating on gelatin (Fig. 5H) . This suggested that the TGF pathway requires Rudhira for activating 387 processes that promote cell migration. Since loss of rudhira results in an inability to activate TGFβ-388 mediated Smad2 signaling, this could lead to an inability to migrate, resulting in angiogenic defects. 389
Further, rudhira depletion cell autonomously affects TGFβ-dependent migration. Alternatively, since 390 Rudhira affects multiple signaling pathways, TGFβ alone may not be sufficient to rescue the effect of 391 rudhira deletion. (23) showed that Rudhira interacts with MT, which prompted us to 398 investigate whether Rudhira is required for MT-regulated TGFβ signaling. Rudhira depletion led to 399 reduced alpha-tubulin as well as acetylated tubulin levels in SVEC endothelial cell line as well as rudhira 400 null primary ECs (Fig. 6A,B) . MTs containing acetylated and detyrosinated tubulin are known to re-401 localize towards the leading edge of a migrating cell (34). In a monolayer wounding assay Rudhira-402 depleted cells showed reduced acetylated tubulin staining, which was not localized towards the leading 403 edge (Fig. 6C) . Further, upon TGF stimulation, wild type ECs (SVEC) showed increased co-localization of 404 Rudhira with MT, suggesting increased binding (Fig. 6D ). This suggests a role for Rudhira in regulating 405
MT architecture and MT-regulated TGFβ signaling. 406 407
Rudhira augments TGFβ pathway activation 408
To test whether Rudhira alone is sufficient to activate the TGFβ pathway, we transfected endothelial 409 cells (SVEC) with a Rudhira overexpression construct (Rudh2AGFP) and analyzed the status of TGF 410 pathway activation. Upon ligand binding to the TGF receptor, Smad2/3 gets activated and translocates 411 to the nucleus (35, 36). Rudhira overexpression alone was not sufficient to activate TGFβ signaling and 412 cause Smad2/3 nuclear localization (Fig. 6E) . However, upon addition of TGFβ1 to the culture, Rudhira 413 overexpressing cells showed markedly increased pathway activation as seen by increased nuclear 414 Smad2/3 in Rud2AGFP transfected cells compared to un-transfected or vector control cells. Further, 415
Rudhira overexpression is unable to overcome the receptor-level inhibition of TGFβ pathway using the 416 small molecule inhibitor SB431542 (SB) that binds to the Alk5 co-receptor, thereby blocking pathway 417 activation (Fig. 6E ). This confirms that Rudhira can augment pathway activity but not substitute for TGF 418 receptor activation. It also indicates that Rudhira functions downstream of the TGF receptor. This is in 419 agreement with the cytoskeletal localization of Rudhira. 420 
Rudhira2AGFP expressing endothelial cells (SVEC). Error bars indicate standard error of mean (SEM). 432
Results shown are a representative of at least three independent experiments with at least three 433 biological replicates taken into account. Statistical analysis was carried out using one-way ANOVA. Scale 434 bar: (B-E) 20 μm. *p<0.05, **p<0.01, ***p<0.001. 435 436 Interestingly, Rudhira overexpression also led to a decrease in smurf2 levels ( Fig. 6F and S7C Fig.) . This 437
indicates that Rudhira augments TGF pathway activation by increasing SMAD2/3 activation, possibly 438 due to a reduction in inhibitor levels. To test whether the converse is true, i.e. whether TGFβ affects 439 Rudhira expression, we treated wild type SVEC cultures with TGFβ1. There was a significant increase in 440 Rudhira transcript and protein levels upon TGFβ induction, as detected by qPCR and 441 immunofluorescence staining (S7A, B Fig.) . This indicates that Rudhira and the TGFβ pathway are 442 mutually dependent for their expression and function. 443
444
Rudhira inhibits Smurf-mediated TGFβ pathway attenuation 445
Our analysis indicated that Rudhira is not an inducer but a promoter of the TGFβ signaling pathway in 446 endothelial cells that acts downstream of receptor-level activation but upstream to SMAD activation. 447 KEGG pathway analysis of the yolk sac transcriptome showed that a majority of the genes involved in 448
TGFβ signaling were deregulated upon rudhira loss. Especially, several antagonists (noggin, follistatin, 449 bambi) and negative regulators (sara, smurf1/2, smad6/7) of the pathway were upregulated (Fig. 5I) . 450 independent experiments with at least two biological replicates. Statistical analysis was carried out using 464 one-way ANOVA. *p<0.05, **p<0.01, ***p<0.001. 465
466
The TGFβ pathway is regulated at multiple steps by a complex combination of activators, inducers and 467 inhibitors (37). Ubiquitin-mediated proteasomal degradation is essential for fine regulation of TGFβ 468 pathway activity in the basal as well as activated states. The E3 ubiquitin ligases for SMADs, namely 469 Smurf1 and Smurf2 (SMAD specific E3 Ubiquitin ligases) are important regulators of the pathway. They 470 control SMAD2/3 levels by ubiquitination and targeting for proteasomal degradation (38, 39). These 471 inhibitors are also targets of TGF pathway activation. 472
Since Rudhira depletion results in increased Smurf1/2 and inhibitory Smad (Smad6 and Smad7) levels, 473
we checked the effect of exogenous TGF addition on these inhibitors. While control cells show a sharp 474 decrease in the levels of these inhibitors upon addition of TGF, Rudhira-depleted cells showed no 475 reduction in their levels, suggesting a loss of control on the negative regulators of TGFβ signaling (Fig.  476   7A ). To test whether increased inhibitor transcript levels co-relate with function, we assayed for levels of 477 ubiquitinated-SMAD2/3 by immuno-pulldown of SMAD2/3 followed by immunoblotting for Ubiquitin. 478
Rudhira depletion indeed results in increased SMAD2/3 ubiquitination, which is markedly increased on 479
TGFβ-mediated activation of the pathway (Fig. 7B) . To further check the status of SMAD2/3 480 ubiquitination in vivo, we performed a Proximity Ligation Assay (PLA) for SMAD2/3 and Ubiquitin in 481 primary endothelial cell cultures derived from E9.5 control and rudh-/-yolk sacs. PLA is a robust and 482 sensitive assay to identify post-translational modifications in proteins specifically and at a single 483 molecule resolution (40). Rudhira knockout cells showed significantly increased SMAD2/3 ubiquitination 484 in vivo (marked by an increase in the number of PLA dots), both in the presence or absence of 485 exogenous TGF β (Fig. 7C) . This indicates that Rudhira promotes TGFβ pathway activation by negatively 486 regulating inhibitors and thereby checking SMAD2/3 ubiquitination. presence of such components, which use ubiquitous elements to shape context-dependent outputs. We 498 therefore chose to analyse the function of Rudhira, a cytoskeletal protein expressed predominantly in 499 the vasculature. 500
501
We report here that global or endothelial-specific deletion of rudhira resulted in mid-gestation lethality 502 with severe defects in cardiovascular patterning and tissue morphogenesis. Based on a transcriptome 503 analysis we identified key steps in blood vessel remodeling such as cell adhesion, migration and 504 modulation of extracellular matrix components that are regulated by the action of Rudhira. We show 505 the essential function of Rudhira in directing endothelial cell migration during development and 506 describe, for the first time, a regulatory network mediated by Rudhira with reference to its interacting 507 partners at both binary (regulatory) as well as physical levels (Fig. 3I) . We propose a model by which 508 Rudhira/BCAS3, an endothelial cell cytoskeletal component, can regulate microtubule-mediated TGF 509 signaling (Fig. 7D) . 510 511 In ECs TGF signaling modulates the transcriptome in a manner that would promote EC migration during 512 angiogenesis (17). Also, in the yolk sac, paracrine TGF-signaling regulates gene expression and ECM 513 production, deposition and remodeling, required for assembly of robust vessels (18). However, the 514 absence of Rudhira hampers TGFβ signaling, negatively affecting endothelial cell migration. Expectedly, 515 rudhira null ECs show a disorganized ECM. Matrix degradation is known to support angiogenesis in 516 multiple ways such as by physical removal of barriers to migration, release of sequestered growth 517 factors or by exposing cryptic protein sequences that function in angiogenesis (28, 44) . MMP activity is 518 essential for releasing TGF for growth factor signaling, which promotes cytoskeletal remodeling seen in 519 mesenchymal migration. In the absence of Rudhira at least some of these angiogenesis promoting 520 events do not occur, resulting in a disorganized matrix, possibly not permissible for directional 521 migration. Though gelatin degradation is reduced upon rudhira depletion, expression of the cognate 522
MMPs (2, 9 etc.) is not altered. We see significant increase in MMP10, MMP21, MMP25 and reduced 523 level of MMP28 transcripts suggesting that this should cause increased degradation. However, MMPs properties. Microtubules regulate TGFβ signaling by binding to and preventing activation of SMADs (19) . 544
Thus our analysis provides a platform for testing cell type-specific cross talk between TGF signaling and 545 the dynamic cytoskeleton in normal development as well as pathological situations such as tumor 546
metastasis. An increase in MT and Rudhira co-localization upon TGFβ stimulation suggests that Rudhira 547 might serve to sequester microtubules thus inhibiting MT and Smad2/3 association and promoting 548 SMAD2/3 phosphorylation (Fig. 6D) . While targeting the interaction of MT with Smads would allow 549 regulation of the TGF pathway, the ubiquitous nature of these molecules is likely to result in 550 widespread and possibly undesirable effects of therapeutic intervention. Rudhira being restricted to the 551 vasculature could provide a suitable tissue-specific target to regulate pathological angiogenesis and 552 TGF pathway activation. 553
554
The presence of cell adhesion assemblies is dependent on the underlying matrix and on whether the 555 surface is rigid as in 2D cell culture or embedded within a 3D ECM (46). Elucidating mechanisms by 556 which Rudhira governs cell migration will be crucial to understanding tumor cell invasion and metastasis. 557
Indeed the upregulation of Rudhira in metastatic tumors underscores its importance (47). Interestingly, 558 TGF cross talks with several other signaling pathways and is a drug target for multiple diseases. Since 559 TGF is also a key inducer of the epithelial/endothelial to mesenchymal transition, it is likely that the 560 cytoskeletal remodeling in these transitions is mediated by Rudhira. Further studies on the role of 561 Rudhira in normal and tumor EMT will be informative. 562
563
Given the large number of signals and their varying levels that EC encounter, it is unlikely that they 564 respond only to one or the same concentration all across the organism. A robust response over a range 565 of signals is likely mediated by molecules that can crosstalk with a wide variety of processes. The 566 cytoskeleton is ideally positioned for this role. EC respond to a variety of signals resulting in a limited 567 repertoire of cytoskeletal changes, which in turn determine cell phenotype. http://www2.clst.riken.jp/arg/mutant%20mice%20list.html) were generated as described, validated by 582 genotyping and crossed to Cre mice to generate knockout mice (see Supporting Information and Fig. 1  583 and S1 Fig.) . 584
585
RT-PCR and qRT-PCR
586
RNA from E9.5 embryos was isolated using TRIzol reagent (Invitrogen). Reverse transcription was 587 performed using 2 μg of DNase treated RNA and Superscript II (Invitrogen, Carlsbad, CA) according to 588 manufacturer's instructions. Quantitative RT-PCR (qRT-PCR) was carried out using EvaGreen (BIO-RAD, 589 CA) in Biorad-CFX96 Thermal cycler (BIO-RAD, CA). Primers used are provided in S7 Table.  590 591
Immunostaining, Immunohistochemistry, Microscopy and analysis
592
Embryos were dissected at desired stages between E7.5 to E11.5, fixed in 4% paraformaldehyde and 593 processed for cryosectioning or immunostaining using standard procedures (48). Primary antibodies 594 used were against Rudhira (23), PECAM1, CD34, Flk1, Ly76 (BD Biosciences), Brachyury (Santa Cruz 595 Biotechnology), laminin, fibronectin, Smooth Muscle Actin, acetylated tubulin, α-tubulin (Sigma 596 Chemical Co. USA), SMAD2/3, pSMAD2 (Cell Signaling Technologies, USA). Secondary antibodies were 597 coupled to Alexa-Fluor 488 or Alexa-Fluor 568 or Alexa-Fluor 633 (Molecular Probes). Cryosections were 598 stained with haematoxylin and eosin using standard protocols. Images were acquired using a stereo 599 zoom (SZX12 Olympus) or inverted (IX70, Olympus) microscope, confocal microscopes (LSM 510 Meta 600 and LSM 700, Zeiss) and a motorized inverted microscope with fluorescence attachment (IX81, 601 Olympus). For details, see Supporting Information. Co-localization analysis was done using co-602 localization plugin in ImageJ (NIH, USA). 603
604
TGFβ induction and analysis 605 Live E10.5 and E11.5 CKO yolk sacs cut into two pieces or embryo-derived cells were washed in PBS and 606 induced with 0 ng/ml (uninduced) or 10 ng/ml of TGFβ in DMEM for 2 h and then fixed and stained for 607 pSMAD2. At least two each of the control and CKO E10.5 yolk sacs were taken for analysis. Non-silencing 608 control (NS) or rudhira knockdown (KD) ECs were induced with 0 or 10 ng/ml of TGFβ in DMEM for 2 h 609 and analysed by immunofluorescence or western blotting for SMAD2/3 and pSMAD2. Non-silencing 610 control (NS) or rudhira knockdown (KD) ECs were induced with 0 or 10 ng/ml of TGFβ in DMEM for 48 h 611 and analysed by qPCR for indicated genes or immunofluorescence for SMAD2/3. 612
613
Western blot analysis and immuno-precipitation 614 50 g lysate from control or knockdown cell lines of SVEC was used for Western blot analysis by 615 standard protocols. Primary antibodies used were: SMAD2/3, pSMAD2 (Cell Signaling Technologies, 616 USA), GAPDH, acetylated tubulin, α-tubulin (Sigma Chemical Co., USA), Ubiquitin (Clone FK2, Biomol) 617 and BCAS3 (Bethyl Labs, USA). HRP conjugated secondary antibodies against appropriate species were 618 used and signal developed by using Clarity Western ECL substrate (Biorad, USA). Western blot intensities 619 were normalised to GAPDH and quantification was carried out using ImageJ. For immuno-precipitation 620 studies, Protein G sepharose beads coated with SMAD2/3 antibody were incubated with cell lysates for 621 4 hours, clarified by centrifugation and extensively washed. Equal volumes of sample were loaded and 622 resolved by SDS polyacrylamide gel and further taken for western blot analysis. 623
624
In situ PLA reaction (Duolink assay) 625
In situ PLA reaction was performed on yolk sac primary cells. The cells were cultured, fixed, 626 permeabilised and stained with primary antibodies for SMAD2/3 and Ubiquitin as mentioned earlier. 
